Empa-Kidney
Research payments
$15,064,127
Through program year 2025, $15,064,127 in research payments was reported against Empa-Kidney, across 2,005 payments.
- Paid by (largest first)
- Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co.KG
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $12,070 | 4 |
| 2024 | Research | $351,270 | 35 |
| 2021 | Research | $6,040,880 | 865 |
| 2020 | Research | $6,340,149 | 732 |
| 2019 | Research | $2,319,758 | 369 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Lance Sloan Lufkin, TX Named on 65 payments
- Pusadee Suchinda Sumter, SC Named on 64 payments
- Radica Alicic Spokane, WA Named on 58 payments
- Ricardo Silva Jacksonville, FL Named on 55 payments
- Reem Mustafa Kansas City, KS Named on 55 payments
- Michael Rocco Winston Salem, NC Named on 53 payments
- Sergio Rovner El Paso, TX Named on 52 payments
- Bradley Eilerman Covington, KY Named on 52 payments
- Srinivasa Beddhu Salt Lake City, UT Named on 51 payments
- Shweta Bansal San Antonio, TX Named on 51 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.